Shunjun Fu
Guangdong Provincial Occupational Disease Prevention Hospital(CN)Zhujiang Hospital(CN)Twelfth Guangzhou City People's Hospital(CN)New York University(US)Southern Medical University(CN)
Publications by Year
Research Areas
Hepatocellular Carcinoma Treatment and Prognosis, MicroRNA in disease regulation, Liver Disease Diagnosis and Treatment, Inflammatory Biomarkers in Disease Prognosis, Cancer, Lipids, and Metabolism
Most-Cited Works
- → Targeting inflammasome/IL-1 pathways for cancer immunotherapy(2016)296 cited
- → Arid1a Has Context-Dependent Oncogenic and Tumor Suppressor Functions in Liver Cancer(2017)249 cited
- → Prognostic significance of neutrophil-lymphocyte ratio in hepatocellular carcinoma: a meta-analysis(2014)235 cited
- → A novel and accurate predictor of survival for patients with hepatocellular carcinoma after surgical resection: the neutrophil to lymphocyte ratio (NLR) combined with the aspartate aminotransferase/platelet count ratio index (APRI)(2016)109 cited
- → Preoperative Aspartate Aminotransferase to Platelet Ratio is an Independent Prognostic Factor for Hepatitis B-Induced Hepatocellular Carcinoma After Hepatic Resection(2014)104 cited
- → Glypican-3 is a potential prognostic biomarker for hepatocellular carcinoma after curative resection(2013)